Actinium Pharmaceuticals's market cap is currently $38.37M. The company's EPS TTM is $-1.397; its P/E ratio is ―; Actinium Pharmaceuticals is scheduled to report earnings on March 14, 2025, and the estimated EPS forecast is $-0.37. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 81.00K	$ 1.03M	$ 1.14M	$ 0.00	$ 0.00
Gross Profit	$ 81.00K	$ 331.00K	$ 620.00K	$ -447.00K	$ -420.09K
Operating Income	$ -51.92M	$ -34.10M	$ -24.96M	$ -22.39M	$ -22.07M
EBITDA	$ -51.13M	$ -33.41M	$ -24.44M	$ -21.77M	$ -21.48M
Net Income	$ -48.82M	$ -31.93M	$ -24.58M	$ -22.04M	$ -21.73M
Balance Sheet
Cash & Short-Term Investments	$ 76.68M	$ 108.91M	$ 77.83M	$ 63.56M	$ 9.25M
Total Assets	$ 81.44M	$ 114.19M	$ 80.39M	$ 66.40M	$ 11.67M
Total Debt	$ 2.11M	$ 2.58M	$ 310.00K	$ 738.00K	$ 1.43M
Net Debt	$ -74.56M	$ -106.33M	$ -77.52M	$ -62.82M	$ -7.83M
Total Liabilities	$ 45.07M	$ 47.71M	$ 6.84M	$ 5.08M	$ 6.03M
Stockholders' Equity	$ 36.38M	$ 66.48M	$ 73.55M	$ 61.32M	$ 5.64M
Cash Flow
Free Cash Flow	$ -47.49M	$ 8.28M	$ -21.00M	$ -21.87M	$ -21.53M
Operating Cash Flow	$ -47.34M	$ 8.64M	$ -20.87M	$ -21.62M	$ -21.46M
Investing Cash Flow	$ -153.00K	$ -366.00K	$ -133.00K	$ -253.00K	$ -63.89K
Financing Cash Flow	$ 14.87M	$ 23.11M	$ 35.22M	$ 76.18M	$ 17.11M

Currency in USD

Actinium Pharmaceuticals Earnings and Revenue History

Income Statement >

Actinium Pharmaceuticals Debt to Assets

Balance Sheet >

Actinium Pharmaceuticals Cash Flow

Cash Flow >

Actinium Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing